In vitro treatment of cardiomyocytes with PKG and PKA respectively reduced Fpassive in both AS groups, although the levels in treated diabetic AS patients remained elevated compared to those in non-diabetic AS patients, supporting the notion that diabetic AS patients exhibit more pronounced changes due to heightened oxidative stress and inflammatory responses. This evidence concerns the gene PRKG1 and aortic valve stenosis.